SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 167 filers reported holding SAGE THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 1.23 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $14,555,000 | +0.8% | 316,065 | -34.1% | 0.48% | -9.3% |
| Q2 2016 | $14,441,000 | -7.5% | 479,275 | -1.6% | 0.53% | -7.4% |
| Q1 2016 | $15,613,000 | -2.6% | 486,985 | +77.2% | 0.57% | +3.1% |
| Q4 2015 | $16,026,000 | +21.7% | 274,885 | -11.7% | 0.55% | +35.0% |
| Q3 2015 | $13,173,000 | -34.3% | 311,265 | +13.3% | 0.41% | -28.2% |
| Q2 2015 | $20,051,000 | +167.6% | 274,665 | +84.1% | 0.57% | +165.4% |
| Q1 2015 | $7,492,000 | – | 149,156 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |